Article
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity.
Nature communications - 28 Feb 2018
Steinhardt James J, Guenaga Javier, Turner Hannah L, McKee Krisha, Louder Mark K, O'Dell Sijy, Chiang Chi-I, Lei Lin, Galkin Andrey, Andrianov Alexander K, A Doria-Rose Nicole, Bailer Robert T, Ward Andrew B, Mascola John R, Li Yuxing
Abstract excerpt
HIV-1 broadly neutralizing antibodies (bNAbs) are being explored as passively administered therapeutic and preventative agents. However, the extensively diversified HIV-1 envelope glycoproteins (Env) rapidly acquire mutations to evade individual bNAbs in monotherapy regimens. The use of a "single" agent to simultaneously target distinct Env epitopes is desirable to overcome viral diversity. Here, we report the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
